The word 'peptide' is now doing two jobs on a label
Three August supplement launches print 'peptide' on the front of the container. The paperwork behind that word is a different kind of document from the one a research-supply buyer reads.
No. 01 Lead story
FDA's 503B Bulks List, assessed as a document rather than a verdict
A public, dated, numbered federal docket that circulates as though it were a register of approved substances. Assessed on what the notices record, how the process moves, and how little of it bears on a research-supply purchase.
Story index
06 stories on file Lot traceability and vial labelling, assessed across the category
The label on a lyophilised vial is the only documentation that physically travels with the material. Assessed on what the category prints, what it omits, and what that costs a buyer.
Cold-chain claims outrun cold-chain evidence in peptide shipping
Suppliers increasingly advertise temperature-controlled shipping. Far fewer publish anything that would let a buyer verify the chain held.
The vendor-published certificate of analysis, assessed as evidence
The COA is the central document in research supply and the least examined. Assessed on what it actually establishes, what it leaves open, and how far a buyer can rely on it.
Third-party assay reports become a competition point in research supply
Vendors of research peptides spent years competing on price per milligram. A growing number now compete on whose laboratory signed the report.
About Labcoat Ledger
Labcoat Ledger — Research peptides, documented not prescribed. Every story indexed, numbered, and timestamped.
Colophon